410 related articles for article (PubMed ID: 16989008)
1. Transplantation of bone marrow genetically engineered to express proinsulin II protects against autoimmune insulitis in NOD mice.
Chan J; Clements W; Field J; Nasa Z; Lock P; Yap F; Toh BH; Alderuccio F
J Gene Med; 2006 Nov; 8(11):1281-90. PubMed ID: 16989008
[TBL] [Abstract][Full Text] [Related]
2. Mixed allogeneic chimerism induced by a sublethal approach prevents autoimmune diabetes and reverses insulitis in nonobese diabetic (NOD) mice.
Li H; Kaufman CL; Boggs SS; Johnson PC; Patrene KD; Ildstad ST
J Immunol; 1996 Jan; 156(1):380-8. PubMed ID: 8598488
[TBL] [Abstract][Full Text] [Related]
3. The effect of bone marrow and thymus chimerism between non-obese diabetic (NOD) and NOD-E transgenic mice, on the expression and prevention of diabetes.
Parish NM; Chandler P; Quartey-Papafio R; Simpson E; Cooke A
Eur J Immunol; 1993 Oct; 23(10):2667-75. PubMed ID: 8405065
[TBL] [Abstract][Full Text] [Related]
4. E expression is needed on both bone marrow derived cells and thymic epithelium to increase IL-4 production and achieve protection in NOD bone marrow chimeras.
Brenden N; Rietz C; Böhme J
Cytokine; 1999 Oct; 11(10):766-72. PubMed ID: 10525315
[TBL] [Abstract][Full Text] [Related]
5. Specific destruction of islet transplants in NOD<-->C57BL/6 and NOD<-->C3H/Tif embryo aggregation chimeras irrespective of allelic differences in beta-cell antigens.
Leijon K; Hillörn V; Bergqvist I; Holmberg D
J Autoimmun; 1995 Jun; 8(3):347-56. PubMed ID: 7575996
[TBL] [Abstract][Full Text] [Related]
6. Inducing Specific Immune Tolerance to Prevent Type 1 Diabetes in NOD Mice.
Liu F; Yao Z; Jiao Q; Cao L; Feng H; Yao S; Li Y; Lü P
Pancreas; 2016 Jul; 45(6):882-8. PubMed ID: 26784909
[TBL] [Abstract][Full Text] [Related]
7. Hematopoietic mixed chimerism derived from allogeneic embryonic stem cells prevents autoimmune diabetes mellitus in NOD mice.
Verda L; Kim DA; Ikehara S; Statkute L; Bronesky D; Petrenko Y; Oyama Y; He X; Link C; Vahanian NN; Burt RK
Stem Cells; 2008 Feb; 26(2):381-6. PubMed ID: 17975228
[TBL] [Abstract][Full Text] [Related]
8. Acceleration of type 1 diabetes mellitus in proinsulin 2-deficient NOD mice.
Thébault-Baumont K; Dubois-Laforgue D; Krief P; Briand JP; Halbout P; Vallon-Geoffroy K; Morin J; Laloux V; Lehuen A; Carel JC; Jami J; Muller S; Boitard C
J Clin Invest; 2003 Mar; 111(6):851-7. PubMed ID: 12639991
[TBL] [Abstract][Full Text] [Related]
9. Intramuscular administration of expression plasmids encoding interferon-gamma receptor/IgG1 or IL-4/IgG1 chimeric proteins protects from autoimmunity.
Chang Y; Prud'homme GJ
J Gene Med; 1999; 1(6):415-23. PubMed ID: 10753067
[TBL] [Abstract][Full Text] [Related]
10. Efficient engraftment of in utero transplanted mice with retrovirally transduced hematopoietic stem cells.
Rio P; Martinez-Palacio J; Ramirez A; Bueren JA; Segovia JC
Gene Ther; 2005 Feb; 12(4):358-63. PubMed ID: 15550924
[TBL] [Abstract][Full Text] [Related]
11. Intravenous administration of proinsulin 1 or 2-expressing fiber-mutant recombinant adenovirus vector protects against the development of diabetes in NOD mice.
Yamada K; Moriyama H; Okumachi Y; Arai T; Kameno M; Kishi M; Yasuda H; Hara K; Yokono K; Nagata M
Ann N Y Acad Sci; 2008 Dec; 1150():183-6. PubMed ID: 19120291
[TBL] [Abstract][Full Text] [Related]
12. Patterns of hemopoietic reconstitution in nonobese diabetic mice: dichotomy of allogeneic resistance versus competitive advantage of disease-resistant marrow.
Kaufman CL; Li H; Ildstad ST
J Immunol; 1997 Mar; 158(5):2435-42. PubMed ID: 9036994
[TBL] [Abstract][Full Text] [Related]
13. Low levels of allogeneic but not syngeneic hematopoietic chimerism reverse autoimmune insulitis in prediabetic NOD mice.
Kaminitz A; Mizrahi K; Yaniv I; Farkas DL; Stein J; Askenasy N
J Autoimmun; 2009 Sep; 33(2):83-91. PubMed ID: 19632089
[TBL] [Abstract][Full Text] [Related]
14. Protection against autoimmune diabetes in mixed bone marrow chimeras: mechanisms involved.
Mathieu C; Casteels K; Bouillon R; Waer M
J Immunol; 1997 Feb; 158(3):1453-7. PubMed ID: 9013991
[TBL] [Abstract][Full Text] [Related]
15. Enhanced green fluorescent protein is a nearly ideal long-term expression tracer for hematopoietic stem cells, whereas DsRed-express fluorescent protein is not.
Tao W; Evans BG; Yao J; Cooper S; Cornetta K; Ballas CB; Hangoc G; Broxmeyer HE
Stem Cells; 2007 Mar; 25(3):670-8. PubMed ID: 17138958
[TBL] [Abstract][Full Text] [Related]
16. Long-term prevention of diabetes and marked suppression of insulin autoantibodies and insulitis in mice lacking native insulin B9-23 sequence.
Nakayama M; Babaya N; Miao D; Gianani R; Liu E; Elliott JF; Eisenbarth GS
Ann N Y Acad Sci; 2006 Oct; 1079():122-9. PubMed ID: 17130542
[TBL] [Abstract][Full Text] [Related]
17. Transgenic expression of decoy receptor 3 protects islets from spontaneous and chemical-induced autoimmune destruction in nonobese diabetic mice.
Sung HH; Juang JH; Lin YC; Kuo CH; Hung JT; Chen A; Chang DM; Chang SY; Hsieh SL; Sytwu HK
J Exp Med; 2004 Apr; 199(8):1143-51. PubMed ID: 15078896
[TBL] [Abstract][Full Text] [Related]
18. Responses against islet antigens in NOD mice are prevented by tolerance to proinsulin but not IGRP.
Krishnamurthy B; Dudek NL; McKenzie MD; Purcell AW; Brooks AG; Gellert S; Colman PG; Harrison LC; Lew AM; Thomas HE; Kay TW
J Clin Invest; 2006 Dec; 116(12):3258-65. PubMed ID: 17143333
[TBL] [Abstract][Full Text] [Related]
19. Unexpected functional consequences of xenogeneic transgene expression in beta-cells of NOD mice.
Leiter EH; Reifsnyder P; Driver J; Kamdar S; Choisy-Rossi C; Serreze DV; Hara M; Chervonsky A
Diabetes Obes Metab; 2007 Nov; 9 Suppl 2():14-22. PubMed ID: 17919174
[TBL] [Abstract][Full Text] [Related]
20. DNA vaccination with an insulin construct and a chimeric protein binding to both CTLA4 and CD40 ameliorates type 1 diabetes in NOD mice.
Chang Y; Yap S; Ge X; Piganelli J; Bertera S; Giannokakis N; Mathews C; Prud'homme G; Trucco M
Gene Ther; 2005 Dec; 12(23):1679-85. PubMed ID: 16107864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
